Pharmacokinetics of estradiol

Pharmacokinetics of Estradiol

Estradiol is a naturally occurring steroid hormone and the primary female sex hormone. It plays a crucial role in the regulation of the menstrual cycle, reproductive system, and the development of secondary sexual characteristics in females. The pharmacokinetics of estradiol, which refers to how the body absorbs, distributes, metabolizes, and excretes the hormone, is a complex process that involves various physiological systems.

Absorption

Estradiol can be administered in several ways, including orally, transdermally, and via injection. The method of administration significantly impacts the absorption of estradiol. Oral administration results in rapid absorption from the gastrointestinal tract, but it also undergoes extensive first-pass metabolism in the liver, which can reduce its bioavailability. Transdermal administration bypasses first-pass metabolism, resulting in higher bioavailability.

Distribution

Once absorbed, estradiol is distributed throughout the body. It binds to sex hormone-binding globulin (SHBG) and albumin in the blood, which transport it to various tissues. Only a small fraction of estradiol remains unbound or "free," and it is this free estradiol that is biologically active.

Metabolism

Estradiol is primarily metabolized in the liver by cytochrome P450 enzymes. The main metabolic pathway involves conversion to estrone and estriol, both of which are less potent estrogens. Other metabolites include catechol estrogens and methoxyestrogens, which have different biological activities.

Excretion

Estradiol and its metabolites are primarily excreted in the urine. Some estradiol is also excreted in the bile and then reabsorbed from the intestine, a process known as enterohepatic circulation.

Factors Affecting Pharmacokinetics

Several factors can affect the pharmacokinetics of estradiol, including age, body mass, liver function, and concomitant medications. For example, aging and obesity can increase the production of SHBG, which can alter the distribution and metabolism of estradiol. Certain medications, such as rifampicin and phenytoin, can induce cytochrome P450 enzymes and increase the metabolism of estradiol.

See Also

• Pharmacodynamics of estradiol
• Pharmacology of steroids
• Endocrinology

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

Pharmacokinetics_of_estradiol

• 
  Estradiol
• 
  Estradiol levels with a single dose of 2 mg oral estradiol micronized to different particle sizes in women
• 
  Estradiol levels during therapy with 0.25 mg buccal estradiol in postmenopausal women
• 
  Estrogen levels after a single 300 μg dose of intranasal estradiol (Aerodiol) in postmenopausal women
• 
  Estrogen patch
• 
  Estrogen levels with 1.25 g of 0.06% transdermal estradiol gel (EstroGel) per day in postmenopausal women
• 
  Estradiol levels with 1.5 or 3.0 mg per day transdermal estradiol gel in postmenopausal women
• 
  Estradiol levels with 1 mg per day transdermal estradiol gel applied to different amounts of area in postmenopausal women
• 
  Estradiol levels with estradiol transdermal spray (brand name Lenzetto) in postmenopausal women
• 
  Estradiol levels with a transdermal estradiol emulsion (brand name Estrasorb) in postmenopausal women